Target type: biologicalprocess
Any positive regulation of glycoprotein biosynthetic process that is involved in immunological synapse formation. [GOC:obol]
Positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation is a critical step in the adaptive immune response. It involves a series of intricate molecular events that lead to the production and modification of glycoproteins, which play crucial roles in the formation and function of the immunological synapse. This specialized structure facilitates the communication between T lymphocytes (T cells) and antigen-presenting cells (APCs), enabling the transfer of signals necessary for T cell activation, proliferation, and differentiation.
The process begins with the transcription and translation of genes encoding glycoproteins, such as adhesion molecules and signaling receptors. These proteins are then transported to the endoplasmic reticulum (ER), where they undergo glycosylation, a process that involves the addition of carbohydrate chains. Glycosylation is essential for the proper folding, stability, and function of glycoproteins. In the ER, glycoproteins interact with chaperone proteins that assist in their folding and prevent misfolding. The ER also acts as a quality control checkpoint, ensuring that only correctly folded glycoproteins are allowed to proceed to the Golgi apparatus.
The Golgi apparatus further modifies glycoproteins through a series of enzymatic reactions. These modifications include the addition of specific sugar residues, the trimming of existing sugar chains, and the formation of complex oligosaccharide structures. These modifications are crucial for the specific recognition and binding of glycoproteins to their respective ligands on the surface of APCs.
Once modified, glycoproteins are packaged into transport vesicles and transported to the plasma membrane. At the plasma membrane, glycoproteins are inserted into the lipid bilayer, where they interact with other molecules, including receptors, adhesion molecules, and signaling proteins. These interactions contribute to the formation of the immunological synapse, a specialized contact zone between T cells and APCs.
Within the immunological synapse, glycoproteins play several important roles. For instance, adhesion molecules, such as integrins, promote the stable adhesion between T cells and APCs. Signaling receptors, such as the T cell receptor (TCR), bind to specific antigens presented on APCs, triggering downstream signaling pathways. These pathways ultimately lead to T cell activation, proliferation, and differentiation into effector T cells that can eliminate pathogens or tumors.
In summary, the positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation is a complex and highly regulated process that is critical for the proper function of the adaptive immune system. This process involves the transcription, translation, glycosylation, and trafficking of glycoproteins, which play crucial roles in the formation and function of the immunological synapse. This specialized structure facilitates the communication between T cells and APCs, enabling the transfer of signals necessary for T cell activation, proliferation, and differentiation.
'"
Protein | Definition | Taxonomy |
---|---|---|
C-C chemokine receptor type 7 | A C-C chemokine receptor type 7 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P32248] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
tak 779 | |||
cenicriviroc | cenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH). cenicriviroc: an inhibitor of HIV-1 | aromatic ether; benzazocine; diether; imidazoles; secondary carboxamide; sulfoxide | anti-HIV agent; anti-inflammatory agent; antirheumatic drug; chemokine receptor 2 antagonist; chemokine receptor 5 antagonist |